S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
Log in

Vor Biopharma Stock Forecast, Price & News

-5.41 (-11.27 %)
(As of 03/2/2021 12:00 AM ET)
Today's Range
Now: $42.59
50-Day Range N/A
52-Week Range
Now: $42.59
Volume290,448 shs
Average Volume315,670 shs
Market Capitalization$1.52 billion
P/E RatioN/A
Dividend YieldN/A
Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.

Industry, Sector and Symbol

Industry Biotechnology
Phone617 655 6580
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$1.52 billion
Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.99 out of 5 stars

Medical Sector

1122nd out of 1,968 stocks

Biotechnology Industry

35th out of 124 stocks

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
-5.41 (-11.27 %)
(As of 03/2/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VOR News and Ratings via Email

Sign-up to receive the latest news and ratings for VOR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Vor Biopharma (NYSE:VOR) Frequently Asked Questions

What stocks does MarketBeat like better than Vor Biopharma?

Wall Street analysts have given Vor Biopharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Vor Biopharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Vor Biopharma's key executives?

Vor Biopharma's management team includes the following people:
  • Dr. Robert Ang M.B.A., MBBS, M.D., Pres, CEO & Director (Age 46)
  • Dr. Siddhartha Mukherjee DPHIL, M.D., Scientific Founder & Chairman of Scientific Advisory Board
  • Dr. Nathan Jorgensen Ph.D., Chief Financial Officer (Age 44)
  • Dr. Sadik Kassim Ph.D., Chief Technology Officer (Age 40)
  • Dr. Tirtha Chakraborty Ph.D., Chief Scientific Officer (Age 47)
  • Ms. Amy Mendel J.D., CLO & Sec. (Age 41)
  • Ms. Tania Philipp, VP & Head of People (Age 49)
  • Dr. Robert G. Pietrusko Pharm.D., Pharm. D., Chief Regulatory and Quality Officer (Age 73)
  • Dr. Christopher Slapak M.D., Chief Medical Officer (Age 62)
  • Mr. John C. King, Chief Commercial Officer (Age 45)

Who are some of Vor Biopharma's key competitors?

When did Vor Biopharma IPO?

(VOR) raised $150 million in an initial public offering (IPO) on Friday, February 5th 2021. The company issued 8,800,000 shares at $16.00-$18.00 per share. Goldman Sachs, Evercore ISI, Barclays and Stifel served as the underwriters for the IPO.

What is Vor Biopharma's stock symbol?

Vor Biopharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "VOR."

When does the company's quiet period expire?

Vor Biopharma's quiet period expires on Wednesday, March 17th. Vor Biopharma had issued 9,828,017 shares in its IPO on February 5th. The total size of the offering was $176,904,306 based on an initial share price of $18.00. During the company's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Vor Biopharma?

Shares of VOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vor Biopharma's stock price today?

One share of VOR stock can currently be purchased for approximately $42.59.

How much money does Vor Biopharma make?

Vor Biopharma has a market capitalization of $1.52 billion.

How many employees does Vor Biopharma have?

Vor Biopharma employs 70 workers across the globe.

What is Vor Biopharma's official website?

The official website for Vor Biopharma is www.vorbiopharma.com.

How can I contact Vor Biopharma?

The company can be reached via phone at 617 655 6580.

This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.